Clinical Trials Browser

Breast Neoplasms, Colonic Neoplasms, Pain, Rectal Neoplasms, Colorectal Neoplasms, Breast Neoplasms, Male, Hand-Foot Syndrome, Drug-Related Side Effects and Adverse Reactions

NCT00085163 2015-10-20

Celecoxib Combined With Fluorouracil and Leucovorin in Treating Patients With Resected Stage III Adenocarcinoma (Cancer) of the Colon

Phase 3 Completed

Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT02537925 2015-09-02

The Effect of COX-2 Inhibitor on Radiosensitivity in Nasopharyngeal Carcinoma

Phase 3 Unknown

120 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT00005094 2013-04-12

Celecoxib to Prevent Colorectal Cancer in Patients Who Have Undergone Surgery to Remove Polyps

Phase 3 Completed

1,170 enrolled

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms

NCT00087256 2013-01-07

Celecoxib in Preventing Polyps in Patients Who Have Undergone Surgery for Stage I Colon Cancer

Phase 3 Terminated

18 enrolled

Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT00064181 2012-09-24

Combination Chemotherapy With or Without Celecoxib in Treating Patients With Metastatic Colorectal Cancer

Phase 3 Completed

86 enrolled

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00981201 2012-08-01

Celecoxib as a Chemopreventive Agent in Current and Former Smokers

Phase 3 Completed

219 enrolled

Smoking

NCT00525096 2011-06-30

Exemestane + Celecoxib vs Exemestane + Placebo in Metastatic Breast Cancer

Phase 3 Completed

157 enrolled

Breast

Breast Neoplasms

NCT00300729 2009-06-30

CYCLUS

Phase 3 Unknown

319 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00603759 2008-01-29

COX-2 Inhibitor With Concurrent Chemoradiation in Locally Advanced Head & Neck Carcinoma

Phase 3 Unknown

122 enrolled

Head & Neck

Head and Neck Neoplasms

NCT00486460 2007-06-14

Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Advance or Inoperable Pancreatic Cancer

Phase 3 Unknown

Gastrointestinal

Pancreatic Neoplasms

NCT00295035 2006-02-22

Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Metastatic Colon Cancer

Phase 3 Unknown

100 enrolled

Gastrointestinal

Colonic Neoplasms

NCT00211952 2005-09-21

Adjuvant Celecoxib in Completely Resected pN1-2 NSCLC Patients

Phase 3 Suspended

542 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

Clinical Trials

Perioperative Analgesia on Postoperative Opioid Usage and Pain Control in H&N Cancer Surgery

Chemopreventive Effect of Combination of Celecoxib and Metformin in Patients With Familial Adenomatous Polyposis

HFS

Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery

CHIP

REACT

Treatment of Severe Influenza A Infection

Parecoxib Versus Celecoxib Versus Oxycodone in Pain Control for Transcatheter Chemoembolization Procedure

XBD

Gemcitabine Hydrochloride or Pemetrexed Disodium and Carboplatin With or Without Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Cancer

Celecoxib in Preventing Hand/Foot Syndrome Caused By Capecitabine With Metastatic Breast or Colorectal Cancer

Celecoxib Combined With Fluorouracil and Leucovorin in Treating Patients With Resected Stage III Adenocarcinoma (Cancer) of the Colon

The Effect of COX-2 Inhibitor on Radiosensitivity in Nasopharyngeal Carcinoma

Celecoxib to Prevent Colorectal Cancer in Patients Who Have Undergone Surgery to Remove Polyps

Celecoxib in Preventing Polyps in Patients Who Have Undergone Surgery for Stage I Colon Cancer

Combination Chemotherapy With or Without Celecoxib in Treating Patients With Metastatic Colorectal Cancer

Celecoxib as a Chemopreventive Agent in Current and Former Smokers

Exemestane + Celecoxib vs Exemestane + Placebo in Metastatic Breast Cancer

CYCLUS

COX-2 Inhibitor With Concurrent Chemoradiation in Locally Advanced Head & Neck Carcinoma

Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Advance or Inoperable Pancreatic Cancer

Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Metastatic Colon Cancer

Adjuvant Celecoxib in Completely Resected pN1-2 NSCLC Patients